FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+16.51%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.31B
AUM Growth
+$1.31B
(+5.1%)
Cap. Flow
+$38.1M
Cap. Flow
% of AUM
2.92%
Top 10 Holdings %
Top 10 Hldgs %
44.12%
Holding
87
New
12
Increased
18
Reduced
18
Closed
37
Top Buys
| 1 |
Natera
NTRA
|
$44.9M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$33.9M |
| 3 |
iRhythm Technologies
IRTC
|
$31.2M |
| 4 |
Insulet
PODD
|
$25.9M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$22.4M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$90.9M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$19.8M |
| 3 |
MODN
MODEL N, INC.
MODN
|
$18.4M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$17.9M |
| 5 |
Biohaven
BHVN
|
$16.4M |
Sector Composition
| 1 | Healthcare | 95.53% |
| 2 | Industrials | 2.52% |
| 3 | Communication Services | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
GSK
GSK
$79.3B
| – | – |
-10,058
| Closed | -$373K |
|
52
AbbVie
ABBV
$374B
| – | – |
-2,540
| Closed | -$394K |
|
|
53
Biohaven
BHVN
$1.71B
| – | – |
-383,757
| Closed | -$16.4M |
|
54
Biogen
BIIB
$20.8B
| – | – |
-1,096
| Closed | -$284K |
|
|
55
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-185,579
| Closed | -$17.9M |
|
56
Centene
CNC
$14.8B
| – | – |
-5,521
| Closed | -$410K |
|
57
Elevance Health
ELV
$72.4B
| – | – |
-886
| Closed | -$418K |
|
58
Enovis
ENOV
$1.75B
| – | – |
-7,203
| Closed | -$404K |
|
59
Exelixis
EXEL
$9.95B
| – | – |
-18,445
| Closed | -$442K |
|
60
Fresenius Medical Care
FMS
$14.3B
| – | – |
-19,490
| Closed | -$406K |
|
61
Gilead Sciences
GILD
$140B
| – | – |
-4,526
| Closed | -$367K |
|
62
Halozyme
HALO
$8.75B
| – | – |
-134,050
| Closed | -$4.95M |
|
63
HCA Healthcare
HCA
$95.4B
| – | – |
-1,160
| Closed | -$314K |
|
64
Humana
HUM
$37.5B
| – | – |
-888
| Closed | -$407K |
|
65
Integra LifeSciences
IART
$1.18B
| – | – |
-7,261
| Closed | -$316K |
|
66
iShares Russell 2000 Growth ETF
IWO
$12.3B
| – | – |
-5,929
| Closed | -$1.5M |
|
67
Johnson & Johnson
JNJ
$429B
| – | – |
-2,161
| Closed | -$339K |
|
68
OrthoPediatrics
KIDS
$524M
| – | – |
-297,509
| Closed | -$9.67M |
|
69
Labcorp
LH
$22.8B
| – | – |
-1,218
| Closed | -$277K |
|
70
Medtronic
MDT
$118B
| – | – |
-4,188
| Closed | -$345K |
|
71
Novartis
NVS
$248B
| – | – |
-4,123
| Closed | -$416K |
|
72
Organon & Co
OGN
$2.56B
| – | – |
-12,716
| Closed | -$183K |
|
73
Olema Pharmaceuticals
OLMA
$432M
| – | – |
-631,064
| Closed | -$8.85M |
|
74
QuidelOrtho
QDEL
$1.87B
| – | – |
-4,257
| Closed | -$314K |
|
75
Qiagen
QGEN
$10.1B
| – | – |
-6,912
| Closed | -$300K |
|